Background And Purpose: The aim of this study was to assess cognitive impairment in patients with relapsing-remitting multiple sclerosis (RR-MS) and to evaluate the correlation of cognitive impairment with physical disability and MRI lesion volume.
Material And Methods: Sixty patients with RR-MS and 50 healthy controls were assessed using neuropsychological tests. All the patients were subjected to MRI examination using PD/T2 and T1 sequences, and clinical evaluation with the EDSS scale was applied.
Results: Selective cognitive impairment was found in 40% of the RR-MS group, and broad, overall cognitive dysfunction was found in 15% of patients. A correlation was found between neurological signs and memory deficits and psychomotor speed. The mean total lesion volume (TLV) was significantly higher in patients with selective and overall cognitive impairment than in those without (8060 vs. 3183 mm3, p=0.001; 7234 vs. 3138 mm3, p=0.004, respectively). There was no difference in TLV between RR-MS patients with selective or overall cognitive impairment (8060 vs. 7234 mm3, p=0.134). Moderate correlations were found between nonverbal memory, verbal fluency and abstract reasoning tests and TLV.
Conclusions: Cognitive impairment is present in more than 50% of patients with RR-MS, and they are mainly selective deficits. The correlation between physical disability and cognitive impairment was not significant, except for memory deficits and psychomotor speed. There is a correlation between TLV and presence of cognitive impairment, but no correlation between TLV and pattern of cognitive impairment.
Download full-text PDF |
Source |
---|
J Diabetes
January 2025
Department of Radiology, Nanjing Drum Tower Hospital, Affiliated Hospital of Medical School, Nanjing University, Nanjing City, Jiangsu Province, China.
Background: Iron is one of the most important elements in brain that may has a direct impact on the stability of central nervous system. The current study devoted to explore the alterations of iron distribution across the whole brain in type 2 diabetes mellitus (T2DM) patients with mild cognitive impairment (MCI).
Methods: The quantitative susceptibility mapping (QSM) technique was used to quantify the intracranial iron content of 74 T2DM patients with MCI and 86 T2DM patients with normal cognition (NC).
J Gen Intern Med
January 2025
Veterans Administration Healthcare System, Portland, OR, USA.
Background: Chronic kidney disease (CKD) is associated with incident cognitive impairment (ICI) and disproportionately affects older adults and Black persons.
Objective: To determine (1) whether age or race differences exist in the association of CKD and ICI and (2) whether cognitive trajectories differ in people with and without CKD.
Design: Nationwide cohort study.
Sci Rep
January 2025
Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei City, Taiwan.
Late-life depression (LLD) is a psychiatric disorder in older adults, characterized by high prevalence and significant mortality rates. Thus, it is imperative to develop objective and cost-effective methods for detecting LLD. Individuals with depression often exhibit disrupted levels of arousal, and microsaccades, as a type of fixational eye movement that can be measured non-invasively, are known to be modulated by arousal.
View Article and Find Full Text PDFBMJ Open
January 2025
Department of Psychology, Uppsala Universitet, Uppsala, Sweden.
Introduction: Premenstrual dysphoric disorder (PMDD) is a cyclic mood disorder affecting around 2%-5% of women of reproductive age. Pharmacological interventions exist, but many patients with PMDD experience residual symptoms, discontinue medications or refrain from them due to side effects. Thus, non-pharmacological treatments are needed as an alternative or additive treatment strategy.
View Article and Find Full Text PDFJ Neurosci
January 2025
Department of Neurobiology and Behavior and Center for the Neurobiology of Learning and Memory, University of California, Irvine, Irvine, California 92697 USA
Cerebral amyloid-beta (Aβ) accumulation, a hallmark pathology of Alzheimer's disease (AD), precedes clinical impairment by two to three decades. However, it is unclear whether Aβ contributes to subtle memory deficits observed during the preclinical stage. The heterogenous emergence of Aβ deposition may selectively impact certain memory domains, which rely on distinct underlying neural circuits.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!